First Tracks Biotherapeutics, Inc. Ordinary Shares (TRAX) is a publicly traded the market company. As of May 21, 2026, TRAX trades at $16.74 with a market cap of $620.74M and a P/E ratio of 0.00. TRAX moved -2.16% today. Year to date, TRAX is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $14.79 to $25.58. Analyst consensus is strong buy with an average price target of $38.50. Rallies surfaces TRAX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
First Tracks Biotherapeutics, Inc. Ordinary Shares (TRAX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. TRAX moved -2.16% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $16.74 |
| Market Cap | $620.74M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $25.58 |
| 52-Week Low | $14.79 |
| Volume | 75 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
6 analysts cover TRAX: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $38.50.